S-1 | 2020-12-23 | Public Filing |
10-Q | 2020-09-30 | Filed 2020-11-06 |
10-Q | 2020-06-30 | Filed 2020-08-06 |
10-Q | 2020-03-31 | Filed 2020-05-08 |
10-K | 2019-12-31 | Filed 2020-03-13 |
10-Q | 2019-09-30 | Filed 2019-11-08 |
10-Q | 2019-06-30 | Filed 2019-08-09 |
10-Q | 2019-03-31 | Filed 2019-05-06 |
10-K | 2018-12-31 | Filed 2019-03-29 |
8-K | 2020-11-24 | |
8-K | 2020-11-20 | |
8-K | 2020-11-10 | |
8-K | 2020-11-06 | |
8-K | 2020-10-30 | |
8-K | 2020-10-07 | |
8-K | 2020-08-24 | |
8-K | 2019-03-22 | |
8-K | 2019-02-05 | |
8-K | 2019-01-31 |
Comps ($'000 TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
---|---|---|---|---|---|---|---|---|---|---|---|
11 Good Energy (ELVN) | |||||||||||
1347 Capital Corp (TFSC) | |||||||||||
1Life Healthcare (ONEM) | |||||||||||
1PM Industries (OPMZ) | |||||||||||
1st Century Bancshares (FCTY) | |||||||||||
1st Financial Services Corp (FFIS) | |||||||||||
1st United Bancorp (FUBC) | |||||||||||
2-Track Global (TTG) | |||||||||||
20 20 Global (TWGL) | |||||||||||
111 (YI) | 0% | 1,546,418 | 322,654 | 0 | 0 | 0 | 0 | -853,740 | |||
1 800 Flowers Com (FLWS) | 944,324 | 42% | 13.3 | 6% | 664,955 | 335,559 | 1,266,390 | 533,727 | 36,761 | 75,090 | 1,000,932 |
10x Genomics (TXG) | 4,804,979 | 75% | -490.3 | -2% | 572,815 | 151,367 | 61,207 | 45,727 | -9,603 | -8,887 | 4,357,180 |
12 Retech (RETC) | 0 | 32% | -0.1 | -1,385% | 1,118 | 20,421 | 625 | 199 | -15,491 | -14,800 | 966 |
1347 Property Insurance Holdings (PIH) | 33,711 | 0% | 0.4 | -5% | 164,088 | 108,405 | 18,194 | 0 | -7,969 | -8,017 | -2,855 |
21st Century Oncology Holdings (RTSX) | |||||||||||
180 Degree Capital (TURN) | |||||||||||
1847 Holdings (EFSH) | 25% | -2.4 | -15% | 18,527 | 23,194 | 27,219 | 6,699 | -2,862 | -1,433 | 3,396 | |
1895 Bancorp of Wisconsin (BCOW) | 46,152,715 | 12,508.1 | -0% | 441,187 | 382,722 | 0 | 0 | -44 | 3,689 | 46,142,359 | |
1st Constitution Bancorp (FCCY) | 164,504 | 0% | 4.4 | 1% | 1,342,565 | 1,204,038 | 490 | 0 | 13,787 | 32,503 | 143,748 |
024 Pharma (EEIG) |
Balance Sheet ($'000) | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Cash | 52 | 1,290 | 271 | 1,450 |
Accounts Receivable | ||||
Inventory | ||||
PP&E | ||||
Assets | 490 | 402,989 | 404,408 | 406,382 |
Accounts Payable | ||||
Long-Term Debt | ||||
Liabilities | 487 | 14,956 | 14,515 | 14,983 |
Stockholders' Equity | 3 | 5,000 | 5,000 | 5,000 |
Income Statement ($'000) | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Revenue | ||||
Cost of Revenue | ||||
Gross Profit | ||||
R&D | ||||
SG&A | ||||
Tax | 278 | 341 | 0 | |
Net Income | -22 | 894 | 1,861 | 1,507 |
Cash Flow ($'000) | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Cash Operating | -123 | 1,643 | 3,242 | 2,032 |
Cash Investing | -401,391 | -2,495 | -853 | |
Cash Financing | 175 | 400,985 | 400,810 | 0 |